亿胜生物科技（股票代码：01061）于2026年5月4日发布截至2026年4月30日的股份变动月报表。公告显示，公司注册股本为10亿股普通股，每股面值为0.1港元，注册股本总额1亿港元。报告期末，公司已发行及流通在外股份总数为567,006,000股，与上月底保持一致，未发生新增发行、购回或注销股份情况。
与此同时，公司2023年6月9日通过的股份期权计划在本月末仍可发行或转让股份数量为57,064,900股，报告期内并无实际行使或新增发行。公司确认已符合香港联交所规定的最低公众持股量要求。
本次月报由董事方海洲签署。公告显示，截至4月底，公司总体股本结构保持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.